Response rates
of patients with headaches to sumatriptan in 4 separate placebo-controlled
studies. Subcutaneous administration,
6 mgm, migraine evaluated at 1 hr; subcautaneous
administration, 6 mgm, cluster headache evaluated at 15 min;
oral administration, 100 mgm, evaluated at 2 hr. (Adapted from
Bateman - 7).